2015
DOI: 10.1021/am5085308
|View full text |Cite
|
Sign up to set email alerts
|

Facile Preparation of Biocompatible and Robust Fluorescent Polymeric Nanoparticles via PEGylation and Cross-Linking

Abstract: Novel cross-linked copolymers of PEG-IM-PhNH2 are successfully synthesized through PEGylation via radical polymerization of 2-isocyanatoethyl methacrylate and poly(ethylene glycol) monomethyl ether methacylate and subsequent cross-linking with an amino-terminated aggregation-induced emission fluorogen. Such obtained amphiphilic copolymers can self-assemble to form uniform fluorescent polymeric nanoparticles (FPNs) and be utilized for cell imaging. These cross-linked FPNs are demonstrated good water dispersibil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
17
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 36 publications
0
17
0
Order By: Relevance
“…Moreover, a passive exploitation of this characteristic leaky vasculature has allowed an increased delivery and accumulation of nanomedicines through sub-endothelial space. Additionally, targeting moieties on nanoparticles’ surface may allow an active accumulation and a controlled drug release into the diseased cells and tissues, reducing toxicity and side-effects [ [23] , [24] , [25] ]. Therefore, many nanomedicines were developed with the aim to treat diseases with an inflammatory background, including cancer [ 26 , 27 ], cardiovascular pathologies [ [28] , [29] , [30] ], autoimmune diseases [ 31 ], metabolic syndrome [ 32 ], neurodegenerative diseases [ 22 , 33 , 34 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, a passive exploitation of this characteristic leaky vasculature has allowed an increased delivery and accumulation of nanomedicines through sub-endothelial space. Additionally, targeting moieties on nanoparticles’ surface may allow an active accumulation and a controlled drug release into the diseased cells and tissues, reducing toxicity and side-effects [ [23] , [24] , [25] ]. Therefore, many nanomedicines were developed with the aim to treat diseases with an inflammatory background, including cancer [ 26 , 27 ], cardiovascular pathologies [ [28] , [29] , [30] ], autoimmune diseases [ 31 ], metabolic syndrome [ 32 ], neurodegenerative diseases [ 22 , 33 , 34 ].…”
Section: Introductionmentioning
confidence: 99%
“…Poly(ethylene glycol) (PEG) is a hydrophilic polymer with a flexible nature that is often selected as the shell-forming segments and can endow the nanoparticles with a stealth character in the blood compartment, thereby achieving long circulation times. [36][37][38][39][40][41][42] More importantly, the PEGylation of nanoparticles guarantees a superb biocompatibility. 43 In this case, the PEGylation of GCC NPs should produce a promising candidate for tracing and biomedical applications.…”
Section: Introductionmentioning
confidence: 99%
“…Among the organic nanomaterials, nanogels constructed by covalently crosslinked polymeric network incorporating fluorophore groups are reasonably supposed to have higher chemical and mechanical stability [12,15] than those constructed through van der Waals forces [1]. For nanogel synthesis, several methods have been developed, including crosslinking the pre-synthesized linear block copolymers by coupling their functional side groups [16,17,18,19], initiating difunctional monomer by using a polymeric macroinitiator, and polymerizing difunctional monomers in a nano-sized emulsion [20,21,22], etc. Recently, the utility of core–shell star-shaped block copolymers as precursors has emerged as a powerful strategy to construct nanoobjects with high controllability over the size and uniformity [23,24].…”
Section: Introductionmentioning
confidence: 99%